1-8 of 8
Authors: Jian Teng
Journal Article
EXTH-60. ONCR-GBM, A NOVEL ARMED ONCOLYTIC HSV-1 VECTOR ENGINEERED FOR EFFICACY AND SAFETY IN GLIOBLASTOMA Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii223, https://doi.org/10.1093/neuonc/noac209.858
Published: 14 November 2022
Journal Article
Corrigendum to: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype Free
Neuro-Oncology, Volume 22, Issue 12, December 2020, Page 1894, https://doi.org/10.1093/neuonc/noaa166
Published: 28 October 2020
Journal Article
THER-03. REPURPOSING MEFLOQUINE AND ANALOGUES FOR DIPG THERAPY Free
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii114, https://doi.org/10.1093/neuonc/noz036.210
Published: 23 April 2019
Journal Article
THER-04. OLFACTORY ENSHEATHING CELLS TRAVEL THEIR NATURE ROUTE FROM NASAL CAVITY TO CNS AND DELIVER THERAPEUTIC TRANSGENES TO HIGH-GRADE PEDIATRIC GLIOMAS Free
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Pages ii114–ii115, https://doi.org/10.1093/neuonc/noz036.211
Published: 23 April 2019
Journal Article
Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype Free
Neuro-Oncology, Volume 20, Issue 5, May 2018, Pages 642–654, https://doi.org/10.1093/neuonc/nox198
Published: 01 November 2017
Journal Article
Dissecting inherent intratumor heterogeneity in patient-derived glioblastoma culture models Free
Neuro-Oncology, Volume 19, Issue 6, 1 June 2017, Pages 820–832, https://doi.org/10.1093/neuonc/now253
Published: 06 January 2017
Journal Article
STEM-18CULTURE CONDITION-INDUCED MESENCHYMAL TRANSITION IN PATIENT-DERIVED GLIOBLASTOMA STEM CELLS Free
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Pages v211–v212, https://doi.org/10.1093/neuonc/nov234.18
Published: 09 November 2015
Journal Article
ATPS-84HYDROXYUREA SENSITIZES PATIENT-DERIVED GLIOBLASTOMA TUMORS TO TEMOZOLOMIDE IRRESPECTIVE OF MGMT STATUS Free
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v37, https://doi.org/10.1093/neuonc/nov204.84
Published: 09 November 2015
